Skip to content

Efficacy of Kangfuxin Solution Irrigation for Ulcerative Non-Puerperal Mastitis: A Randomized Controlled Trial Using a 2×2 Factorial Design

Observation on the efficacy of Recovery Xin liquid irrigation combined with air cupping for pus drainage in the treatment of suppurative stage non-lactating mastitis.

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2026000088
Enrollment
Unknown
Registered
2026-01-17
Start date
2021-06-01
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non-Puerperal Mastitis

Interventions

Treatment Group:Kangfuxin Solution Irrigation
Control Group:Normal Saline Irrigation

Sponsors

The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine)
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1) Female patients aged 18 to 75 years (inclusive); 2) A confirmed diagnosis of PCM or GLM based on pathology and clinical symptoms; 3) Being in the ulcerated stage of the disease, i.e., presenting with an unhealed skin breach following spontaneous rupture or surgical incision and drainage.; 4) Consent to undergo the sinus tract irrigation procedure and providing written informed consent; 5) Willingness to be randomly assigned to a treatment group and to participate in the intervention and follow-up.

Exclusion criteria

Exclusion criteria: 1) Pathological findings indicating tuberculosis or malignant tumor cells; 2) Pregnant or breastfeeding patients; 3) Patients concurrently participating in other clinical trials; 4) Patients with severe cardiac, hepatic, or renal dysfunction, or those with uncontrolled hypertension or diabetes; 5) Patients with poor compliance or those unable to complete the study interventions and follow-up.

Design outcomes

Primary

MeasureTime frame
Therapeutic efficacy;

Secondary

MeasureTime frame
Inflammatory Mass Size;Visual Analog Scale (VAS) Pain Scores;Duration of Intervention;Recurrence Rate;

Countries

China

Contacts

Public ContactXiufei Gao

The First Affiliated Hospital of Zhejiang Chinese Medical University

gaoxiufei@zcmu.edu.cn13868186611

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 7, 2026